That’s right Sp is governed by future revenue But my napkin figures are ignored $5 just for DMD in Europe Listening to JG he said we could get revenue from all DMD boys Ambulant and Non Ambulant .. And that’s just DMD… CG and JG see a different Coy to people on this thread.. they see a CSL.. Few years down the track no doubt.. A Coy that will pay dividends. $$ CSL are starting a Phase 1 in Asthma Anp has already been down that track and are in Phase 2?… just need $$$ Asthma is a $21 billion market..
ANP Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
